LifeWatch’s remote diagnostic monitoring services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. Digital health is a rapidly advancing sector that is playing an ever important role in the trend towards a more holistic approach to diagnosing, treating and monitoring diseases. LifeWatch specialises in ECG-based cardiac monitoring devices and systems. H115 revenues rose 9.1% to $52.5m, driven by growth in the US market, and the firm posted its best EBIT ($3.8m) and EBITDA ($7.2m) numbers since 2009.
